Bain, Cinven to take over Stada in €5.3bn deal
The Frankfurt-listed pharmaceutical company has accepted the pair’s offer of €66 a share.
10 April 2017•3 mins read
The Frankfurt-listed pharmaceutical company has accepted the pair’s offer of €66 a share.
Japanese GP returns entire debut fund with first exit
29 September 2026 · 2 mins read
Carlyle leans into carve-outs as dealmaking gets more competitive
24 September 2026 · 3 mins read
Number Crunch: The road to cyber resilience
22 September 2026 · 3 mins read
Why growth and buyout strategies are becoming harder to distinguish
22 September 2026 · 4 mins read
Managers struggle with AI diligence due to pace of development
10 September 2026 · 3 mins read
Mid-market CEOs demand more from GPs
10 September 2026 · 2 mins read
PE's exit backlog is a readiness problem
8 September 2026 · 4 mins read
